HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

J. Biol. Chem., Vol. 277, Issue 39, 35896-35905, September 27, 2002

This Article Full Text Full Text (PDF) All Versions of this Article: 277/39/35896    most recent M205644200v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by deCarvalho, A. C. V. Articles by Teem, J. L. Search for Related Content PubMed PubMed Citation Articles by deCarvalho, A. C. V. Articles by Teem, J. L. Social Bookmarking                      What's this?

Mutations in the Nucleotide Binding Domain 1 Signature Motif Region Rescue Processing and Functional Defects of Cystic Fibrosis Transmembrane Conductance Regulator F508^*

Ana C. V. deCarvalho, Lisa J. Gansheroff, and John L. Teem

From the Department of Biological Science, Florida State University, Tallahassee, Florida 32306

The gene encoding the cystic fibrosis transmembrane conductance regulator (CFTR), an ATP binding cassette (ABC) transporter that functions as a phosphorylation- and nucleotide-regulated chloride channel, is mutated in cystic fibrosis (CF) patients. Deletion of a phenylalanine at amino acid position 508 (F508) in the first nucleotide binding domain (NBD1) is the most prevalent CF-causing mutation and results in defective protein processing and reduced CFTR function, leading to chloride impermeability in CF epithelia and heterologous systems. Using a STE6/CFTRF508 chimera system in yeast, we isolated two novel F508 revertant mutations, I539T and G550E, proximal to and within the conserved ABC signature motif of NBD1, respectively. Western blot and functional analysis in mammalian cells indicate that mutations I539T and G550E each partially rescue the CFTRF508 defect. Furthermore, a combination of both revertant mutations resulted in a 38-fold increase in CFTRF508-mediated chloride current, representing 29% of wild type channel activity. The G550E mutation increased the sensitivity of CFTRF508 and wild type CFTR to activation by cAMP agonists and blocked the enhancement of CFTRF508 channel activity by 2 mM 3-isobutyl-1-methylxanthine. The data show that the F508 defect can be significantly rescued by second-site mutations in the nucleotide binding domain 1 region, that includes the LSGGQ consensus motif.

CiteULike

Complore

Connotea

Del.icio.us

Digg

Reddit

Technorati

This article has been cited by other articles:

				Y. Wang, T. W. Loo, M. C. Bartlett, and D. M. Clarke Correctors Promote Maturation of Cystic Fibrosis Transmembrane Conductance Regulator (CFTR)-processing Mutants by Binding to the Protein J. Biol. Chem., November 16, 2007; 282(46): 33247 - 33251. [Abstract] [Full Text] [PDF]

				M. Roxo-Rosa, Z. Xu, A. Schmidt, M. Neto, Z. Cai, C. M. Soares, D. N. Sheppard, and M. D. Amaral Revertant mutants G550E and 4RK rescue cystic fibrosis mutants in the first nucleotide-binding domain of CFTR by different mechanisms PNAS, November 21, 2006; 103(47): 17891 - 17896. [Abstract] [Full Text] [PDF]

				H. A. Lewis, X. Zhao, C. Wang, J. M. Sauder, I. Rooney, B. W. Noland, D. Lorimer, M. C. Kearins, K. Conners, B. Condon, et al. Impact of the {Delta}F508 Mutation in First Nucleotide-binding Domain of Human Cystic Fibrosis Transmembrane Conductance Regulator on Domain Folding and Structure J. Biol. Chem., January 14, 2005; 280(2): 1346 - 1353. [Abstract] [Full Text] [PDF]

				X. Wang, J. Matteson, Y. An, B. Moyer, J.-S. Yoo, S. Bannykh, I. A. Wilson, J. R. Riordan, and W. E. Balch COPII-dependent export of cystic fibrosis transmembrane conductance regulator from the ER uses a di-acidic exit code J. Cell Biol., October 11, 2004; 167(1): 65 - 74. [Abstract] [Full Text] [PDF]